In the tumor microenvironment, the IL-6R/STAT3 signaling pathway acted to promote tumor growth and progression37, and elevated circulating levels of IL-6 have been reported in patients with pancreatic38, breast39, colorectal40, and ovarian41 cancer types, among others. This evidence concerns the gene STAT3 and neoplasm.